Literature DB >> 17219186

[Coagulopathy in multiple trauma: new aspects of therapy].

O Grottke1, D Henzler, D R Spahn, R Rossaint.   

Abstract

Coagulopathy after trauma is a major cause for uncontrolled hemorrhage in trauma victims. Approximately 40% of trauma related deaths are attributed to or caused by exsanguination. Therefore the prevention of coagulopathy is regarded as the leading cause of avoidable death in these patients. Massive hemorrhage after trauma is usually caused by a combination of surgical and coagulopathic bleeding. Coagulopathic bleeding is multifactorial, including dilution and consumption of both platelets and coagulation factors, as well as dysfunction of the coagulation system. Because of the high mortality associated with hypothermia, acidosis and progressive coagulopathy, this vicious circle is often referred to as the lethal triad, potentially leading to exsanguination. To overcome this coagulopahty-related bleeding an empiric therapy is often instituted by replacing blood components. However, the use of transfusion of red blood cells has been shown to be associated with post-injury infection and multiple organ failure. In the management of mass bleeding it is therefore crucial to have a clear strategy to prevent coagulopathy and to minimize the need for blood transfusion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17219186     DOI: 10.1007/s00101-006-1120-6

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  41 in total

Review 1.  Management of massive blood loss: a template guideline.

Authors:  D Stainsby; S MacLennan; P J Hamilton
Journal:  Br J Anaesth       Date:  2000-09       Impact factor: 9.166

Review 2.  Perioperative systemic haemostatic agents.

Authors:  A M Mahdy; N R Webster
Journal:  Br J Anaesth       Date:  2004-07-26       Impact factor: 9.166

Review 3.  Updates in the management of severe coagulopathy in trauma patients.

Authors:  Mauricio Lynn; Igor Jeroukhimov; Yoram Klein; Uri Martinowitz
Journal:  Intensive Care Med       Date:  2002-10       Impact factor: 17.440

Review 4.  Emerging off-label uses for recombinant activated factor VII: grading the evidence.

Authors:  T Miko Enomoto; Per Thorborg
Journal:  Crit Care Clin       Date:  2005-07       Impact factor: 3.598

5.  Blood transfusion. An independent risk factor for postinjury multiple organ failure.

Authors:  F A Moore; E E Moore; A Sauaia
Journal:  Arch Surg       Date:  1997-06

6.  Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited.

Authors:  N Cosgriff; E E Moore; A Sauaia; M Kenny-Moynihan; J M Burch; B Galloway
Journal:  J Trauma       Date:  1997-05

7.  Changes in coagulation and fibrinolysis occurring in dogs during hypothermia.

Authors:  H Yoshihara; T Yamamoto; H Mihara
Journal:  Thromb Res       Date:  1985-02-15       Impact factor: 3.944

8.  Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

Authors:  Kenneth David Boffard; Bruno Riou; Brian Warren; Philip Iau Tsau Choong; Sandro Rizoli; Rolf Rossaint; Mads Axelsen; Yoram Kluger
Journal:  J Trauma       Date:  2005-07

9.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

Review 10.  Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials.

Authors:  S J Stanworth; S J Brunskill; C J Hyde; D B L McClelland; M F Murphy
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

View more
  2 in total

Review 1.  [Treatment of polytrauma in the intensive care unit].

Authors:  V Mann; S Mann; G Szalay; M Hirschburger; R Röhrig; C Dictus; T Wurmb; M A Weigand; M Bernhard
Journal:  Anaesthesist       Date:  2010-08       Impact factor: 1.041

Review 2.  Perioperative coagulopathy monitoring.

Authors:  A Jakoi; N Kumar; A Vaccaro; K Radcliff
Journal:  Musculoskelet Surg       Date:  2013-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.